 |
인쇄하기
취소
|
Hanmi's Slimmer is spotlighted in Japan
Hanmi Pharm's Slimmer (sibutramine mesylate), a generic anti-obesity drug of Reductil (sibutramine), is a forerunner in domestic weight loss drug market, according to Japan's prominently daily Sankei Shinmoon.
It took four years for Hammi to develop Slimmer with an investment of 3.7 billion won, with successful completion of clinical phase I and III trials.
In its special edition on metab...
It took four years for Hammi to develop Slimmer with an investment of 3.7 billion won, with successful completion of clinical phase I and III trials.
In its special edition on metab...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.